Back to top
more

Agilent Technologies (A)

(Delayed Data from NYSE)

$123.75 USD

123.75
1,475,965

+0.36 (0.29%)

Updated Sep 29, 2025 04:00 PM ET

After-Market: $123.78 +0.03 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (150 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.

Zacks Equity Research

Agilent (A) Gears Up for Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal third-quarter 2019 results.

Zacks Equity Research

Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

The Truth About Market Timing - July 30, 2019

by Zacks Equity Research

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Zacks Equity Research

Agilent to Acquire BioTek, Cell Analysis Portfolio to Expand

by Zacks Equity Research

Agilent Technologies (A) enters into an agreement to buy BioTek Instruments, which is likely to strengthen its cell analysis capabilities and expand presence in life science research space.

Sanghamitra Saha headshot

5 Top & Flop ETF Areas of Q2

by Sanghamitra Saha

Dovish Fed comments and chances of U.S.-China trade truce kept the market steady in the second quarter. These ETF areas won and lost in the second quarter.

Shilpa Mete headshot

Electronics Testing Equipment Industry Outlook Appears Bright

by Shilpa Mete

Prospects of the Electronics - Testing Equipment industry look bright, thanks to the increasing proliferation of electronic devices in every major sector.

Zacks Equity Research

Agilent Announces Receipt of FDA Approval for pharmDX Assay

by Zacks Equity Research

Agilent (A) receives approval on the expanded use of its PD-L1 IHC 22C3 pharmDx assay.

Zacks Equity Research

Why Is Agilent (A) Up 3.9% Since Last Earnings Report?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sanghamitra Saha headshot

Tense About Trade War? Follow Goldman With 5 ETF Strategies

by Sanghamitra Saha

Amid heightened US-China trade tensions, investors can land up on five ETF strategies and follow the suggestions of Goldman Sachs.

Zacks Equity Research

Agilent (A) Misses Earnings and Revenue Estimates in Q2

by Zacks Equity Research

Agilent (A) reports weak fiscal second-quarter results due to slowing global demand in small molecule Pharma and softness in the China Food market.

Zacks Equity Research

Agilent Technologies (A) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of -1.39% and -2.30%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Agilent (A) Gears Up for Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal second-quarter 2019 results.

Zacks Equity Research

Vishay Intertechnology (VSH) Q1 Earnings Top, Revenues Up Y/Y

by Zacks Equity Research

Vishay Intertechnology's (VSH) first-quarter results benefit from solid end market momentum and robust MOSFET, capacitors and, resistors and inductors.

Zacks Equity Research

Mettler-Toledo (MTD) Earnings & Revenues Top Estimates in Q1

by Zacks Equity Research

Mettler-Toledo (MTD) first-quarter 2019 results benefit from well-performing Laboratory and Industrial product lines.

Zacks Equity Research

Booking Holdings (BKNG) Q1 Earnings & Revenues Lag Estimates

by Zacks Equity Research

Currency headwinds and shift in Easter timing impact Booking Holdings' (BKNG) first-quarter 2019 results.

Zacks Equity Research

StoneCo (STNE) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

StoneCo's (STNE) improved features, capabilities and differentiated services that help its clients better manage businesses are likely to aid its first-quarter 2019 results.

Zacks Equity Research

Can New Offerings & Buyouts Aid Cisco's (CSCO) Q3 Earnings?

by Zacks Equity Research

Cisco???s (CSCO) expanding footprint in the rapidly growing security market and acquisition synergies are likely to positively impact third-quarter results.

Zacks Equity Research

Tencent Music (TME) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Tencent Music's (TME) first-quarter 2019 results are likely to benefit from expanding music library despite increasing content and revenue sharing fees.

Zacks Equity Research

Alibaba (BABA) Gears Up for Q4 Earnings: What's in Store?

by Zacks Equity Research

Alibaba's (BABA) fourth-quarter fiscal 2019 results are likely to be driven by strength in core e-commerce business. However, trade tensions and competition remain concerns.

Zacks Equity Research

MACOM (MTSI) Q2 Loss Wider Than Expected, Revenues Fall Y/Y

by Zacks Equity Research

MACOM's (MTSI) fiscal second-quarter results bear the impact of softness in datacenter and telecom markets.

Zacks Equity Research

Advanced Energy (AEIS) Q1 Earnings Beat, Revenues Down Y/Y

by Zacks Equity Research

Advanced Energy Industries' (AEIS) first-quarter results benefit from strong industrial revenues. However, softness in semiconductor market impacted the top line.

Zacks Equity Research

Factors Likely to Decide JD.com's (JD) Fate in Q1 Earnings

by Zacks Equity Research

Strength in e-commerce business and international expansion are likely to drive JD.com's first-quarter earnings. However, sluggishness in the third party logistics services unit remains a concern.

Zacks Equity Research

Itron (ITRI) Earnings and Revenues Surpass Estimates in Q1

by Zacks Equity Research

Improving customer demand and well-performing networked solutions benefit Itron's (ITRI) first-quarter results.

Zacks Equity Research

Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

What's in Store for Booking Holdings' (BKNG) Q1 Earnings?

by Zacks Equity Research

Booking Holdings' (BKNG) Q1 earnings are likely to reflect strength in all platforms.